|
Exosomal drug formulations
|
1R41CA189517-01
|
$225,000
|
|
GUPTA, RAMESH
|
3P BIOTECHNOLOGIES, INC.
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
1P20CA192976-01
|
$144,556
|
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
Distance Education to Engage Alaskan Community Health Aides in Cancer Control
|
1R25CA186882-01
|
$210,042
|
|
CUEVA, MELANY
|
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
|
|
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
|
1R01CA182284-01A1
|
$346,525
|
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Targeting PML for therapy in leukemia-initiating cells
|
5R00CA139009-05
|
$241,530
|
|
ITO, KEISUKE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
|
1F31CA183493-01A1
|
$47,676
|
|
OHAEGBULAM, KIM
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
(PQB4) Age-cancer interplay of genome and epi-genome in human lung
|
5R01CA180126-02
|
$679,887
|
|
VIJG, JAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The B7x pathway in the tumor microenvironment
|
3R01CA175495-01A1S1
|
$59,075
|
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Nemours Community Clinical Oncology Program
|
3U10CA176879-01S1
|
$89,460
|
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
The Impact of a Targeted CRC Screening Intervention among Latinos in Central PA
|
5K01CA151752-04
|
$137,943
|
|
DOMINIC, ORALIA
|
ALLEGHENY-SINGER RESEARCH INSTITUTE
|
|
Global Proteomic Screening by MALDI Spectrometric Imaging of Protein-Bead Arrays
|
2R44CA161965-03
|
$499,745
|
|
LIM, MARK
|
AMBERGEN, INC
|
|
Seventh AACR Conference on The Science of Health Disparities in Racial/Ethnic Min
|
1R13CA192732-01
|
$74,000
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Nicotine Deprivation and Implicit Motivational Processes of Drinking and Smoking
|
3R03CA175870-01A1S1
|
$40,302
|
|
COHN, AMY
|
AMERICAN LEGACY FOUNDATION
|
|
Real-Time Patterns of Smoking and Alcohol Use: A Daily Data Analysis
|
5R03CA175870-02
|
$117,817
|
|
COHN, AMY
|
AMERICAN LEGACY FOUNDATION
|
|
Social Dynamics of Substance Use in Online Social Networks for Smoking Cessation
|
1R01CA192345-01
|
$468,382
|
|
GRAHAM, AMANDA
|
AMERICAN LEGACY FOUNDATION
|
|
Examining Social Influences on Young Adult Smoking and Cessation Trajectories
|
1R03CA187756-01
|
$73,842
|
|
VILLANTI, ANDREA
|
AMERICAN LEGACY FOUNDATION
|
|
Development of breakthrough intra-operative detector and imaging system for parat
|
9R42CA192243-02A1
|
$591,600
|
|
MAHADEVAN-JANSEN, ANITA
|
ANASYS INSTRUMENTS CORPORATION
|
|
American Indian mHealth Smoking Dependence study (PQ4)
|
7R01CA170336-03
|
$505,033
|
|
PETEREIT, DANIEL
|
AVERA MCKENNAN
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
The Study of the Circadian Rhythm in p53 Signaling
|
3R01CA137019-05S1
|
$94,661
|
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Study of the Circadian Rhythm in p53 Signaling
|
5R01CA137019-05
|
$282,481
|
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
ESTROGEN RECEPTOR TARGETED TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
|
5K23CA160664-02
|
$142,986
|
|
GODOY, GUILHERME
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
5P50CA126752-08
|
$2,162,000
|
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
3R01CA164024-02S1
|
$3,941
|
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor
|
1R01CA187202-01
|
$636,476
|
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Neurocognitive Outcomes Following Proton Beam Radiation Therapy for Treatment of
|
5K07CA157923-04
|
$148,746
|
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Lung Cancer Prediction Models Incorporating Exome Data from Extreme Phenotypes
|
1K07CA181480-01A1
|
$127,739
|
|
LIU, YANHONG
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
1P50CA186784-01
|
$2,162,000
|
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Oncology Clinical Research Training Program
|
3K12CA090433-13S1
|
$129,088
|
|
POPLACK, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
1R01CA175026-01A1
|
$405,847
|
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
|
1R01CA181808-01A1
|
$369,215
|
|
RICHARDS, JOANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells
|
1R01CA174808-01A1
|
$326,348
|
|
SHOHET, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
3R01CA166749-02S1
|
$51,202
|
|
ZAGE, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
|
1U01CA187956-01
|
$595,990
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-29S1
|
$86,403
|
|
NICHOLS, CRAIG
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
|
5R01CA183605-02
|
$520,769
|
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Integrating Competing Risks into the CISNET DFCI Breast Cancer Model
|
1R21CA180793-01A1
|
$245,039
|
|
MCCARTHY, ELLEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Controlling cancer with aspirin-triggered stimulation of resolution
|
5R01CA170549-03
|
$490,642
|
|
PANIGRAHY, DIPAK
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Integrated models for metastatic phenotype and outcome prediction in osteosarcoma
|
1R01CA178908-01A1
|
$379,336
|
|
SPENTZOS, DIMITRIOS
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
3R01CA079830-13S1
|
$66,893
|
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S5
|
$110,177
|
|
KACHNIC, LISA
|
BOSTON MEDICAL CENTER
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
1R01CA181392-01A1
|
$309,536
|
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Uncoupling obesity from breast cancer in African American women
|
5U01CA182898-02
|
$588,563
|
|
DENIS, GERALD
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
Total relevant funding to Contraception and Reproduction Research for this search: $4,933,521
|